"This is the first time we've seen improvement in fibrosis that was observed in participants with compensated cirrhosis due ...

Naim Alkhouri, MD, spoke to the potential for glucagon-like peptide-1 (GLP-1) receptor agonists to transform the treatment ...

Once-monthly efimosfermin alfa prescribed for metabolic dysfunction–associated steatohepatitis with F2 and F3 fibrosis ...

AMSTERDAM — A once daily, 50 mg dose of efruxifermin reduced fibrosis at 96 weeks in patients with compensated cirrhosis due to metabolic dysfunction-associated steatohepatitis (MASH) compared with ...

Because nothing tests your patience — or your posture — like youth sports season. NEW YORK , NY May 6, 2025 With Mother's Day ...

A phase 3 trial shows that once-weekly semaglutide significantly improves liver histology in patients with metabolic ...

This local sensation mashes up pop and rock hits with a full brass section, turning every show into a high-energy singalong.

Since its historic FDA approval in March 2024 as the first medication for the treatment of the prevalent liver disease ...

Target RWE, a leader in modern clinical evidence generation for complex diseases, today announced its presentations and strategic contributions at the EASL Congress 2025 in Amsterdam, Netherlands.

The Muse moves in mysterious ways, I just follow her lead. This year at Jazz Fest, she led me back to a series of DIY fest food mash-ups. I toyed around with this idea a few years back ...

Some have been standing there for over an hour. The band that’s worth the wait? Brass Mash. Aptly named, Brass Mash is a local SLO County all-brass instrument mash-up band. “It’s not a jazz ...